Organization: Health Canada
Year: 2023
Month: October
Request Number: A-2020-000017
Request Summary: In relation to the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review in August 2017, please provide any Notices of Deficiency (NOD); Notices of Non-Compliance (NON); NOD-Withdrawal or NON-Withdrawal .
Disposition: Disclosed in part
Number of pages: 12